Artigos de revistas sobre o tema "MEIS Inhibitors"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "MEIS Inhibitors".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Kocabas, F., S. N. Eren, M. Uslu e M. Y. Yuksel. "P69Identification of cardiogenic and hematopoietic MEIS Inhibitors". Cardiovascular Research 114, suppl_1 (1 de abril de 2018): S18—S19. http://dx.doi.org/10.1093/cvr/cvy060.033.
Texto completo da fonteGİRGİN, Birkan, Medine KARADAĞ-ALPASLAN e Fatih KOCABAŞ. "Oncogenic and tumor suppressor function of MEIS and associated factors". TURKISH JOURNAL OF BIOLOGY 44, n.º 6 (14 de dezembro de 2020): 328–55. http://dx.doi.org/10.3906/biy-2006-25.
Texto completo da fonteBarbosa, Karina, Anagha Deshpande, Ping Xiang, Bo-Rui Chen, Adam Brown, Neil Robertson, Younguk Sun et al. "High-Density Domain-Focused CRISPR Screens Reveal Epigenetic Regulators of Hox/Meis Gene Expression in Acute Myeloid Leukemia". Blood 136, Supplement 1 (5 de novembro de 2020): 2–3. http://dx.doi.org/10.1182/blood-2020-141412.
Texto completo da fonteBisaillon, Richard, Eva Schmidt, Anne-Sophie Guenier e Guy Sauvageau. "Identification of MEIS-PBX inhibitors as potential anti-leukemic agents using a high-throughput bret-based assay". Experimental Hematology 41, n.º 8 (agosto de 2013): S51. http://dx.doi.org/10.1016/j.exphem.2013.05.201.
Texto completo da fonteCastellet, Helena, Guillermo Ramil López, Ana Garrido, Alícia Artigas-Baleri, Marta Pratcorona, Olga Salamero, Albert Cortés-Bullich et al. "Ubtf tandem Duplications Define a Novel Subtype of Acute Myeloid Leukemia Associated with Younger Age, WT1 Mutations and HOXA9 Marked Overexpression". Blood 142, Supplement 1 (28 de novembro de 2023): 6045. http://dx.doi.org/10.1182/blood-2023-186064.
Texto completo da fonteBreitinger, Constanze, Emanuel Maethner, Maria-Paz Garcia-Cuellar, Alexandra Schambony, Kirsten Schilling, Klaus D. Fischer e Robert K. Slany. "Hox Genes Regulate Rac1 Activity Through Control of Vav2 expression". Blood 118, n.º 21 (18 de novembro de 2011): 60. http://dx.doi.org/10.1182/blood.v118.21.60.60.
Texto completo da fonteJarocha, Danuta Jadwiga, Paul Gadue, Wei Tong, Robert C. Newton e Mortimer Poncz. "Janus Kinase (Jak) 1 Inhibition Affects Both Megakaryopoiesis and Thrombopoiesis". Blood 132, Supplement 1 (29 de novembro de 2018): 2559. http://dx.doi.org/10.1182/blood-2018-99-115407.
Texto completo da fonteHaneline, Laura S., Khadijeh R. Bijangi-Vishehsaraei, Adam Werne, Kristina Wilson McKenzie, Susanna Davis, Hidenori Ichijo e Mohammad R. Saadatzadeh. "TNF-α Hypersensitivity of Fanconi Anemia Type C Deficient Cells Is Dependent on the Apoptosis Signal-Regulating Kinase 1 Signaling Pathway." Blood 104, n.º 11 (16 de novembro de 2004): 724. http://dx.doi.org/10.1182/blood.v104.11.724.724.
Texto completo da fonteWang, Wei, Peng Li, Annette Schettino, Zhe Peng e Maureen McLeod. "Characterization of Functional Regions in the Schizosaccharomyces pombe mei3 Developmental Activator". Genetics 150, n.º 3 (1 de novembro de 1998): 1007–18. http://dx.doi.org/10.1093/genetics/150.3.1007.
Texto completo da fonteKAYA, Mustafa Oğuzhan. "Out-of-mind Inhibitors Of Human Serum Paraoxonase 1 (PON1): An In Vitro study". Middle East Journal of Science 3, n.º 1 (26 de agosto de 2017): 59–77. http://dx.doi.org/10.23884/mejs.2017.3.1.07.
Texto completo da fonteAgarwal, Archana, Gregory Russell Pond, Catherine Curran, Amin Nassar, Pier Vitale Nuzzo, Vivek Kumar, Bradley Alexander McGregor et al. "Impact of concurrent medications on outcomes with PD1/PD-L1 inhibitors for metastatic urothelial carcinoma." Journal of Clinical Oncology 37, n.º 7_suppl (1 de março de 2019): 435. http://dx.doi.org/10.1200/jco.2019.37.7_suppl.435.
Texto completo da fonteAltman, Jessica K., Heather Glaser, Amanda Redig, Antonella Sassano, Martin S. Tallman e Leonidas C. Platanias. "Targeting the Mnk Pathway Enhances Chemotherapy-Induced Antileukemic Responses." Blood 112, n.º 11 (16 de novembro de 2008): 1617. http://dx.doi.org/10.1182/blood.v112.11.1617.1617.
Texto completo da fonteWaters, Andrew Michael, Wen-Hsuan Chang, Clint Stalnecker, Cole Edwards, Runying Yang, Craig M. Goodwin, Adrienne D. Cox e Channing J. Der. "Abstract 1075: Identification of resistance mechanisms to direct KRAS inhibition in pancreatic cancer". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 1075. http://dx.doi.org/10.1158/1538-7445.am2023-1075.
Texto completo da fonteMattos, Daphne R., Xuemei Wan, Jeffrey D. Serrill, Minh H. Nguyen, Ian R. Humphreys, Benoit Viollet, Amos B. Smith, Kerry L. McPhail e Jane E. Ishmael. "The Marine-Derived Macrolactone Mandelalide A Is an Indirect Activator of AMPK". Marine Drugs 20, n.º 7 (27 de junho de 2022): 418. http://dx.doi.org/10.3390/md20070418.
Texto completo da fonteDelgado, Irene, Alejandra C. López-Delgado, Alberto Roselló-Díez, Giovanna Giovinazzo, Vanessa Cadenas, Laura Fernández-de-Manuel, Fátima Sánchez-Cabo, Matthew J. Anderson, Mark Lewandoski e Miguel Torres. "Proximo-distal positional information encoded by an Fgf-regulated gradient of homeodomain transcription factors in the vertebrate limb". Science Advances 6, n.º 23 (junho de 2020): eaaz0742. http://dx.doi.org/10.1126/sciadv.aaz0742.
Texto completo da fonteSchevzov, Galina, Anthony J. Kee, Bin Wang, Vanessa B. Sequeira, Jeff Hook, Jason D. Coombes, Christine A. Lucas et al. "Regulation of cell proliferation by ERK and signal-dependent nuclear translocation of ERK is dependent on Tm5NM1-containing actin filaments". Molecular Biology of the Cell 26, n.º 13 (julho de 2015): 2475–90. http://dx.doi.org/10.1091/mbc.e14-10-1453.
Texto completo da fonteIhlefeld, Katja, Ralf Frederik Claas, Alexander Koch, Josef M. Pfeilschifter e Dagmar Meyer zu Heringdorf. "Evidence for a link between histone deacetylation and Ca2+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts". Biochemical Journal 447, n.º 3 (5 de outubro de 2012): 457–64. http://dx.doi.org/10.1042/bj20120811.
Texto completo da fonteHamaguchi, Yukiyoshi, Steven K. Juhn e Yasuo Sakakura. "Protease Inhibitors in Middle Ear Effusions from Experimental Otitis Media with Effusion: Kinetics of α1-Antitrypsin and α2-Macroglobulin Levels". Annals of Otology, Rhinology & Laryngology 98, n.º 4 (abril de 1989): 287–92. http://dx.doi.org/10.1177/000348948909800410.
Texto completo da fonteKundu, Mondira, Chia-Ying Yang, Kelly McCastlain, Junmin Wu, Ji Zhang, Tullia Lindsten, Paul Ney e Craig B. Thompson. "Hsp90 regulates Ulk1-mediated autophagic clearance of mitochondria". Blood 112, n.º 11 (16 de novembro de 2008): 3458. http://dx.doi.org/10.1182/blood.v112.11.3458.3458.
Texto completo da fonteWeddle, Carly, e Paul Burridge. "Abstract A070: Examining patient-specific responses to PARP inhibitors in a novel, human induced pluripotent stem cell-based model of breast cancer". Cancer Research 84, n.º 3_Supplement_1 (1 de fevereiro de 2024): A070. http://dx.doi.org/10.1158/1538-7445.advbc23-a070.
Texto completo da fonteYu, Lanlan, Baohui Wang, Xurui Sun e Jian Song. "Synthesis and properties of a MEAS quadripolymer scale inhibitor". Desalination and Water Treatment 52, n.º 10-12 (16 de maio de 2013): 1865–71. http://dx.doi.org/10.1080/19443994.2013.792014.
Texto completo da fonteRenaldo, Kyle, Shelby Sloan, JiHyun Chung, Lindsay Courtney, Konstantin Shilo, William Kisseberth e Robert A. Baiocchi. "Exploring PRMT5 As a Potential Therapeutic Target in Canine Lymphomas". Blood 132, Supplement 1 (29 de novembro de 2018): 4182. http://dx.doi.org/10.1182/blood-2018-99-119115.
Texto completo da fonteAlexander, D. L., L. G. Ganem, P. Fernandez-Salguero, F. Gonzalez e C. R. Jefcoate. "Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis". Journal of Cell Science 111, n.º 22 (15 de novembro de 1998): 3311–22. http://dx.doi.org/10.1242/jcs.111.22.3311.
Texto completo da fonteLambert, Michele P., Yuhuan Wang, M. Anna Kowalska e Mortimer Poncz. "Negative Paracrine Effect of Platelet Factor 4 on Megakaryopoiesis Occurs through Lipoprotein Related Protein Receptor-1 on Megakaryocytes." Blood 110, n.º 11 (16 de novembro de 2007): 97. http://dx.doi.org/10.1182/blood.v110.11.97.97.
Texto completo da fonteKhan, Husain Yar, Sahar Bannoura, Hirva Mamdani, Amro Aboukameel, Yousef Mzannar, Yiwei Li, Mohammad Najeeb Al-Hallak et al. "Abstract 5315: Anti-tumor activity of KRASG12C inhibitors is enhanced when combined with Cdc42 effector p21-activated kinase 4 targeting agents". Cancer Research 82, n.º 12_Supplement (15 de junho de 2022): 5315. http://dx.doi.org/10.1158/1538-7445.am2022-5315.
Texto completo da fonteNigam, Aradhya, Walid K. Chatila, Gnana P. Krishnamoorthy, Alan L. Ho, James A. Fagin, Nikolaus D. Schultz e Brian R. Untch. "Abstract 1181: PTEN loss-of-function mutations prevalent in HRAS-mutant cancers results in resistance to targeted therapy". Cancer Research 82, n.º 12_Supplement (15 de junho de 2022): 1181. http://dx.doi.org/10.1158/1538-7445.am2022-1181.
Texto completo da fonteZhou, Yang, Sahar Alimohamadi, Li Wang, Ziqing Liu, Joseph B. Wall, Chaoying Yin, Jiandong Liu e Li Qian. "A Loss of Function Screen of Epigenetic Modifiers and Splicing Factors during Early Stage of Cardiac Reprogramming". Stem Cells International 2018 (2018): 1–14. http://dx.doi.org/10.1155/2018/3814747.
Texto completo da fonteTanajura, Luiz, Áurea Chaves, Andrea Abizaid e José Costa Júnior. "Monotherapy with P2Y12 receptor inhibitors in patients treated by percutaneous coronary intervention". Journal of Transcatheter Interventions 29 (2 de dezembro de 2021): 1–9. http://dx.doi.org/10.31160/jotci202129a202106.
Texto completo da fonteDinchuk, Joseph E., Carolyn Cao, Fei Huang, Karen A. Reeves, Jeanne Wang, Fanny Myers, Glenn H. Cantor et al. "Insulin Receptor (IR) Pathway Hyperactivity in IGF-IR Null Cells and Suppression of Downstream Growth Signaling Using the Dual IGF-IR/IR Inhibitor, BMS-754807". Endocrinology 151, n.º 9 (7 de julho de 2010): 4123–32. http://dx.doi.org/10.1210/en.2010-0032.
Texto completo da fonteHamaguchi, Yukiyoshi, Yuichi Majima, Kenji Sakakura e Yasuo Sakakura. "Lysosomal Thiol Proteases in Middle Ear Effusions". Annals of Otology, Rhinology & Laryngology 95, n.º 3_suppl (maio de 1986): 9–12. http://dx.doi.org/10.1177/00034894860950s303.
Texto completo da fonteDizaye, Kawa F., e Asmaa A. Ahmed. "Renoprotective Evaluations of Different Angiotensin Inhibitors on Diabetic Nephropathy in Rats". Middle East Journal of Internal Medicine 9, n.º 3 (novembro de 2016): 3–11. http://dx.doi.org/10.5742/meim.2016.92897.
Texto completo da fonteMack, Fiona A., Jagruti H. Patel, Mangatt P. Biju, Volker H. Haase e M. Celeste Simon. "Decreased Growth of Vhl−/− Fibrosarcomas Is Associated with Elevated Levels of Cyclin Kinase Inhibitors p21 and p27". Molecular and Cellular Biology 25, n.º 11 (1 de junho de 2005): 4565–78. http://dx.doi.org/10.1128/mcb.25.11.4565-4578.2005.
Texto completo da fonteShim, Sungbo, Yujin Kim, Jongdae Shin, Jieun Kim e Soochul Park. "Regulation of EphA8 Gene Expression by TALE Homeobox Transcription Factors during Development of the Mesencephalon". Molecular and Cellular Biology 27, n.º 5 (18 de dezembro de 2006): 1614–30. http://dx.doi.org/10.1128/mcb.01429-06.
Texto completo da fonteSun, Jun, Juan Kong, Yingli Duan, Frances L. Szeto, Anne Liao, James L. Madara e Yan Chun Li. "Increased NF-κB activity in fibroblasts lacking the vitamin D receptor". American Journal of Physiology-Endocrinology and Metabolism 291, n.º 2 (agosto de 2006): E315—E322. http://dx.doi.org/10.1152/ajpendo.00590.2005.
Texto completo da fonteYerlikaya, Azmi, Scot R. Kimball e Bruce A. Stanley. "Phosphorylation of eIF2α in response to 26S proteasome inhibition is mediated by the haem-regulated inhibitor (HRI) kinase". Biochemical Journal 412, n.º 3 (28 de maio de 2008): 579–88. http://dx.doi.org/10.1042/bj20080324.
Texto completo da fonteSaadatzadeh, M. Reza, Khadijeh Bijangi-Vishehsaraei e Laura S. Haneline. "The Role of Stress Activated Protein Kinases in Promoting Fanconi Anemia Hematopoietic Stem and Progenitor Cell Dysfunction". Blood 112, n.º 11 (16 de novembro de 2008): 1043. http://dx.doi.org/10.1182/blood.v112.11.1043.1043.
Texto completo da fonteIshida, Yoji, Syugo Kowata, Kazunori Murai, Tatsuo Oyake e Shigeki Ito. "TAT/HDL Induces the Phospholylation of Cofilin in the Process of Platelet Production of Megakaryocytes." Blood 104, n.º 11 (16 de novembro de 2004): 2186. http://dx.doi.org/10.1182/blood.v104.11.2186.2186.
Texto completo da fonteSealover, Nancy, Bridget Finniff e Robert Kortum. "Abstract B033: Wild-type RAS signaling is an essential therapeutic target in RAS-mutated cancers". Molecular Cancer Research 21, n.º 5_Supplement (1 de maio de 2023): B033. http://dx.doi.org/10.1158/1557-3125.ras23-b033.
Texto completo da fonteRubin, Elina, Agnese C. Pippione, Matthew Boyko, Giacomo Einaudi, Stefano Sainas, Massimo Collino, Carlo Cifani et al. "A New NF-κB Inhibitor, MEDS-23, Reduces the Severity of Adverse Post-Ischemic Stroke Outcomes in Rats". Brain Sciences 12, n.º 1 (28 de dezembro de 2021): 35. http://dx.doi.org/10.3390/brainsci12010035.
Texto completo da fonteGRILL, Constance, Ferdous GHEYAS, Priya DAYANANTH, Weihong JIN, Wei DING, Ping QIU, Luquan WANG, Ronald J. DOLL e Jessie M. ENGLISH. "Analysis of the ERK1,2 transcriptome in mammary epithelial cells". Biochemical Journal 381, n.º 3 (27 de julho de 2004): 635–44. http://dx.doi.org/10.1042/bj20031688.
Texto completo da fonteTergaonkar, Vinay, Virginie Bottero, Masahito Ikawa, Qiutang Li e Inder M. Verma. "IκB Kinase-Independent IκBα Degradation Pathway: Functional NF-κB Activity and Implications for Cancer Therapy". Molecular and Cellular Biology 23, n.º 22 (15 de novembro de 2003): 8070–83. http://dx.doi.org/10.1128/mcb.23.22.8070-8083.2003.
Texto completo da fonteTanajura, Luiz, Áurea Chaves, Rafaela Freitas, Ana Barbosa, Kelvyn Vital e José Delamain. "Aspirin versus P2Y12 inhibitors for secondary prevention after percutaneous coronary intervention". Journal of Transcatheter Interventions 31 (14 de dezembro de 2023): 1–7. http://dx.doi.org/10.31160/jotci202331a202304.
Texto completo da fonteVanzyl, Erin J., Hadil Sayed, Alex B. Blackmore, Kayleigh R. C. Rick, Pasan Fernando e Bruce C. McKay. "The spliceosome inhibitors isoginkgetin and pladienolide B induce ATF3-dependent cell death". PLOS ONE 15, n.º 12 (28 de dezembro de 2020): e0224953. http://dx.doi.org/10.1371/journal.pone.0224953.
Texto completo da fonteMukherjee, Kaustav, Bruce Futcher e Janet Leatherwood. "mmi1 and rep2 mRNAs are novel RNA targets of the Mei2 RNA-binding protein during early meiosis in Schizosaccharomyces pombe". Open Biology 8, n.º 9 (setembro de 2018): 180110. http://dx.doi.org/10.1098/rsob.180110.
Texto completo da fonteGreene, Teshell K., Li Zhai, Beatrice Razzo, Karen Vo, Denise E. Sabatino, Rodney M. Camire, Valder R. Arruda e Mortimer Poncz. "Platelet Factor VIII-Induced Megakaryocyte Apoptosis: Implications for Hemophilia A Gene Therapy". Blood 120, n.º 21 (16 de novembro de 2012): 2051. http://dx.doi.org/10.1182/blood.v120.21.2051.2051.
Texto completo da fonteKariya, Shin, Mitsuhiro Okano, Katsuya Aoji, Michiya Kosaka, Emiko Chikumoto, Hisashi Hattori, Koji Yuen, Shinji Nishioka, Keiko Nishioka e Kazunori Nishizaki. "Role of Macrophage Migration Inhibitory Factor in Otitis Media with Effusion in Adults". Clinical Diagnostic Laboratory Immunology 10, n.º 3 (maio de 2003): 417–22. http://dx.doi.org/10.1128/cdli.10.3.417-422.2003.
Texto completo da fonteÇAKMAK, Reşit, Ercan ÇINAR, Eyüp BAŞARAN e Mehmet BOĞA. "SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL EVALUATION OF ESTER DERIVATIVES OF 4-(DIETHYLAMINO)SALICYLALDEHYDE AS CHOLINESTERASE, AND TYROSINASE INHIBITORS". Middle East Journal of Science 7, n.º 2 (30 de dezembro de 2021): 137–44. http://dx.doi.org/10.51477/mejs.947973.
Texto completo da fonteLuciana, Luciana, Firdha Senja Maelaningsih e Diah Permata Sari. "PENGGUNAAN PROTON PUMP INHIBITOR PADA PASIEN RAWAT JALAN DI RSIA DHIA CIPUTAT TANGERANG SELATAN". Edu Masda Journal 6, n.º 1 (18 de abril de 2022): 36. http://dx.doi.org/10.52118/edumasda.v6i1.151.
Texto completo da fonteSealover, Nancy E., e Robert L. Kortum. "Abstract 413: WT RAS signaling is an essential therapeutic target in RAS mutated cancers". Cancer Research 82, n.º 12_Supplement (15 de junho de 2022): 413. http://dx.doi.org/10.1158/1538-7445.am2022-413.
Texto completo da fonteMinami, Kahori, Yukihiro Tambe, Ryosuke Watanabe, Takahiro Isono, Masataka Haneda, Ken-ichi Isobe, Toshiyuki Kobayashi et al. "Suppression of Viral Replication by Stress-Inducible GADD34 Protein via the Mammalian Serine/Threonine Protein Kinase mTOR Pathway". Journal of Virology 81, n.º 20 (1 de agosto de 2007): 11106–15. http://dx.doi.org/10.1128/jvi.01063-07.
Texto completo da fonte